semaglutide .50 mg weight loss 50 of oral #semaglutide daily was associated with body reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj and reduced Considering taking Wegovy to lose

Abstract The advent of incretin mimetics such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has enriched the armamentarium for diabetes management owing to their glycaemic as well as extra-glycaemic benefits

Cest en 1905 qu'elle fut identifie par des chercheurs russes et allemands

Grauslund (Int J of Retina and Vitreous 2024) published a large cohort study using the Danish public health data

[DOI] [PMC free article] [PubMed] [Google Scholar] Franz D, Contreras F, Gonzlez H, Prado C, Elgueta D, Figueroa C, Pacheco R (2015) Dopamine receptors D3 and D5 regulate CD4(+)T-cell activation and differentiation by modulating ERK activation and cAMP production

doi: 10.1056/NEJMe2406487